Fight 9 Types Of Cancer Using Cannabis 

According to research, cannabidiol can prevent the growth of breast cancer. Another study confirmed that use of cannabinoids and THC slow growth of breast cancer cells. Cannabis can also reduce the size of breast cancer tumors.

Do I Have to Avoid Sugar and Other Carbs?

The science concerning the best diet to prevent cancer and cancer recurrence is a work in progress, but I think that conventional oncology underestimates the importance of diet. As patients, it behooves us to be proactive and do our best to protect ourselves.

Breast Cancer Patients Warned About Grilled and Smoked Meats, Even Fish, in Study

Meats cooked at high temperatures, as are grilled, barbecued and smoked meats, have long been associated with carcinogenic chemicals like polycyclic aromatic hydrocarbons. According to a press release, consuming foods with these carcinogens is also linked to breast cancer incidence. Researchers led by Humberto Parada Jr. at the University of North Carolina at Chapel Hill looked at whether a diet rich in such meats also affected survival after breast cancer — and found that regular and even light consumption of some meats prepared this way, especially smoked meats, had an impact.

Researchers Conclude Wireless Radiation Causes Cancer

Professor of Oncology Lennart Hardell, MD, PhD, and Statistician Michael Carlberg of Orebro University Hospital, Sweden found a 3-fold risk with 25 or more years of cell and cordless phone use in a study published October 2014 in Pathophysiology. Very significant was the finding that people who first used mobile or cordless phones before the age of 20 had the highest risk.

Breast cancer survivors walk the runway topless at empowering NYFW show 

Sixteen women of all ages and sizes hit the catwalk for an emotionally charged Art Hearts Fashion show on Sunday during New York Fashion Week. Each of the ladies walked the runway in AnaOno loungewear and lingerie pieces — oh, and pretty much all of them whipped off their bras and strutted topless too. These women, the youngest of whom is only 18 years old, are all cancer survivors with the mastectomy scars to prove it. The show was about these strong ladies (and breast cancer survivors everywhere, really) reclaiming their bodies and their confidence and giving a big middle finger to the disease, which, according to breastcancer.org, effects one in eight women in the U.S. per year.

Breast Cancer Drugs Stop Working When Tumors Make Their Own Estrogen

They analyzed samples from 150 women whose cancer had metastasized following surgery and found that 25 percent of patients taking aromatase inhibitors showed increased expression of aromatase in their cancer cells, which occurred though the amplification, or increase in number, of aromatase genes. By increasing the amount of aromatase, the cancer cells could produce their own estrogen without needing external sources, making them resistant to the aromatase inhibitors.

Breast cancer patients with dense breast tissue more likely to develop cancer in the other breast

“Our findings have valuable implications for both newly diagnosed patients with dense breasts and for breast cancer survivors as we manage their long-term risk of a secondary diagnosis,” said Barcenas. Our future goal is to develop a risk model incorporating breast density to best assess a breast cancer survivor’s risk of developing cancer in the other breast. In the long-term, the researchers hope to use this tool to counsel patients on their personal risk and their options for treatment and surveillance, if their risk is sufficiently high.

Do Mammograms Lead to Overdiagnosis of Breast Cancer? 

Danish research took advantage of a natural experiment. Some regions of the country started providing routine mammography a decade or more before the rest of the country. The investigators compared breast cancer diagnoses and deaths between two regions, one with mammogram screening and one without. As a result, they concluded that mammography did not reduce the number of advanced breast tumors. That would have been the desired outcome. Instead, mammography discovered some breast tumors that might not have needed treatment. Discriminating between aggressive tumors and indolent ones is difficult, even for experts.

Lumpectomy Plus Radiation May Beat Mastectomy for Early Breast Cancer

Women with early stage breast cancer may survive longer if they opt for the less-extensive surgery called lumpectomy, followed by radiation, rather than a mastectomy, a new study suggests. In the current study, lumpectomy patients not only lived longer, but were also less likely to have a cancer recurrence in the lymph nodes near the breast, or at other sites in the body. Lumpectomy plus radiation may also carry fewer complications and lower costs.

The Truth About Cholesterol Levels & Cancer Most MDs Don’t Know

Women with the highest cholesterol levels had the lowest risk of breast cancer. In fact, the number was 30% lower. The same study found women had a 39% lower risk of melanoma and a 39% lower risk of lymphoma/leukemia when their cholesterol levels were the highest. Total cholesterol as a measurement is so 1970s. If your doctor is measuring this, ask for advanced lipid testing. This would include LDL particles and HDL particles. You need to know the number of particles and the size of the particles. These measurements are so much more relevant than total cholesterol, total LDL and total HDL. In fact, the ratio of LDL particles to HDL particles is the best prognosticator of all lipid parameters.

Is Emotional Stress Increasing Your Breast Cancer Risk?

While Western medicine may not recognize it, the idea that emotional distress can contribute to the development of cancer has been known since ancient times in China. Traditional Chinese medicine (TCM) considers that all internal or chronic diseases are caused by the seven major emotions − anger, shock, joy, fear, brooding, anxiety, and sorrow.

Dozens of new cancer drugs do little to improve survival

Overall cancer survival has barely changed over the past decade. The 72 cancer therapies approved from 2002 to 2014 gave patients only 2.1 more months of life than older drugs, according to a study in JAMA Otolaryngology–Head & Neck Surgery. And those are the successes. Two-thirds of cancer drugs approved in the past two years have no evidence showing that they extend survival at all.